Six young scientists to receive 2012 Klerman and Freedman Awards

NewsGuard 100/100 Score

Six young scientists will be recognized with the Annual Klerman and Freedman Awards by the Brain & Behavior Research Foundation on Friday July 27, 2012 at Le Parker Meriden Hotel in New York City on Friday, July 27.

The 2012 Klerman Prizewinner,Jess G. Fiedorowicz, M.D.,Ph.D., assistant professor at the University of Iowa and 2008 NARSAD Young Investigator Grantee, addresses the major public health issue of vascular disease in mood disorders by seeking to understand the most relevant mechanisms underlying the high rate of associated morbidity so that novel means to mitigate the risk may be developed. The Klerman Prize was established in 1994 in memory of Gerald Klerman, M.D.,to honor outstanding achievements in clinical mental health research by a young investigator.

The 2012 Freedman Prizewinner, Zhiping Pang, M.D.,Ph.D.,assistant professor at the Robert Wood Johnson Medical School University of Medicine & Dentistry of New Jersey and 2008 NARSAD Young Investigator Grantee, has developed a novel way to study synaptic dysfunction in brain and behavior disorders, including schizophrenia and bipolar disorder. Building upon advances in stem cell biology, the research team successfully converted mouse and human cells into functional neurons (iN cells), providing a completely new window for studying neural development, modeling neurological disease and furthering regenerative medicine. The Freedman Prize was established in 1998 in memory of Daniel X. Freedman, M.D. to recognize outstanding basic mental health research by a young investigator.

The prizewinners are selected by committees within the Brain & Behavior Research Foundation Scientific Council, a volunteer group of 132 of the world's leading mental health researchers. Herbert Pardes, M.D., presides over the Council and selection committees and said, "NARSAD Young Investigator Grantees offer the promise of outstanding mental health research. These young scientists being honored demonstrate exceptional talent and are moving us forward in the quest for better understanding of and improved treatments for brain and behavior disorders."

The following two 2008 NARSAD Young Investigator Grantees will receive 2012 Klerman Prize Honorable Mentions:

Johanne Renaud, M.D. M.S.,associate professor at McGill University, is a dedicated child and adolescent psychiatrist developing evidence-based suicide prevention standards for youth.

Manpreet Kaur Singh, M.D., M.S.,assistant professor at Stanford University is using new technologies, including neuroimaging, genetic analyses and neurobehavioral assessment to identify the underlying mechanisms that lead to the development of mood disorders in youth.

The following two 2008 NARSAD Young Investigator Grantees will receive 2012 Freedman Prize Honorable Mentions:

Marie Carlén, Ph.D.,assistant professor at the Karolinska Institutet in Stockholm, Sweden, is implementing optogenetics to establish the physiological and cellular basis of cognitive deficits in brain and behavior disorders such as schizophrenia.

Genevieve Konopka, Ph.D., assistant professor at the University of Texas Southwestern Medical Center, is developing cutting edge techniques to identify candidate genes for novel therapies in autism and schizophrenia.

"We are proud to support a new generation of researchers pioneering the way toward important advances, unlocking the mysteries of mental illness, and helping to relieve the suffering of those afflicted," said Benita Shobe, Brain & Behavior Research Foundation President and CEO.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer